Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, September 25, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
FDA Grants Priority Review to ENHERTU and Pertuzumab Combination for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Life Sciences Times
-
September 24, 2025
Pharma
Actio Biosciences Doses First Participant in Phase 1 Trial of ABS-1230 for KCNT1-Related Epilepsy
Life Sciences Times
-
September 23, 2025
Pharma
FDA Issues Complete Response Letter for Scholar Rock’s Apitegromab, Citing Catalent Facility Observations
Life Sciences Times
-
September 23, 2025
Pharma
Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine
Life Sciences Times
-
September 23, 2025
Pharma
KalVista Wins EU, Swiss Approvals for EKTERLY, First Oral On-Demand Therapy for Hereditary Angioedema
Life Sciences Times
-
September 19, 2025
Pharma
Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial
Life Sciences Times
-
October 31, 2022
0
Pharma
Takeda Becomes First Enterprise to Achieve Diamond Tier Status as a Best in Resilience™ Certified Organization
Life Sciences Times
-
October 27, 2022
0
Pharma
Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce First Paragraph IV Filing and Acceptance by FDA
Life Sciences Times
-
October 27, 2022
0
Pharma
Gilead Presents Real-World Evidence Reinforcing the Use of Biktarvy® for the Treatment of People Living With HIV With a Range of Comorbidities
Life Sciences Times
-
October 24, 2022
0
Pharma
Novaliq Announces FDA Acceptance of the New Drug Application for CyclASol® for the Treatment of Dry Eye Disease
Life Sciences Times
-
October 24, 2022
0
Pharma
Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® Tablets for the Treatment of Chorea Associated with Huntington’s Disease
Life Sciences Times
-
October 18, 2022
0
Pharma
Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for Cholestatic Pruritus
Life Sciences Times
-
October 14, 2022
0
Pharma
CHMP recommends conditional marketing authorization for Spesolimab as first in class treatment option for generalized pustular psoriasis flares
Life Sciences Times
-
October 14, 2022
0
Pharma
CANbridge-UMass Chan Medical School Gene Therapy Research in Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 29th Annual Congress
Life Sciences Times
-
October 14, 2022
0
Pharma
4Moving Biotech Announces First Patient Enrolled in Phase I Clinical Trial on Osteoarthritis
Life Sciences Times
-
October 14, 2022
0
Pharma
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
Life Sciences Times
-
October 12, 2022
0
Pharma
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Gilead’s Trodelvy® for Pre-Treated HR+/HER2- Metastatic Breast Cancer
Life Sciences Times
-
October 11, 2022
0
1
...
35
36
37
...
80
Page 36 of 80
Most Read
Future Family Names Alden Romney CEO, Founder Claire Tomkins Transitions to Executive Chair
September 24, 2025
Groups Names Cooper Zelnick as CEO to Lead Next Phase of Growth in Value-Based Addiction Care
September 24, 2025
MEDiC Life Sciences Acquires Clinical-Stage Oncology Program, Leveraging Biomarker Platform for Precision Medicine
September 24, 2025
AVS Expands with New Waltham Headquarters as It Prepares for U.S. Launch of PULSE IVL System
September 24, 2025